PlumX Metrics
Embed PlumX Metrics

Development and validation of a pentaplex PCR assay for rapid detection of bla CTX-M, bla OXA–1 , bla CMY, bla NDM and the PBP3 insert in Enterobacterales

Indian Journal of Medical Microbiology, ISSN: 0255-0857, Vol: 52, Page: 100710
2024
  • 0
    Citations
  • 0
    Usage
  • 15
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

There is a high diversity of beta-lactamases in gram negative pathogens, making them difficult to treat. In the presence of OXA-1 and ampC, PTZ is no longer clinically relevant when treating Enterobacterales expressing ESBLs. Further, MBL infections are often treated with the combination of ceftazidime/avibactam with aztreonam.. It has recently been reported that NDM-expressing E. coli isolates co-harboring PBP3 insert develops resistance to this triple combination. A pentaplex PCR is developed and validated to simultaneously detect bla CTX-M, bla OXA-1, bla CMY, bla NDM, and the PBP3 insert in whole genome sequenced E. coli and K. pneumoniae isolates. In addition, the isolates chosen for pentaplex PCR evaluation were tested for their minimum inhibitory concentrations (MICs) against piperacillin/tazobactam, cefoperazone/sulbactam (C/S), ertapenem, imipenem, meropenem, ceftazidime/avibactam, aztreonam/avibactam, cefepime/taniborbactam, and cefiderocol. The developed pentaplex PCR showed 100 % reproducibility with the antimicrobial resistance profile generated from whole genome sequenced data. PTZ and C/S are not effective against ESBL and/or OXA-1 expressing E. coli and K. pneumoniae isolates and do not offer any activity against CMY co-producers. Further, the combined effect of CMY, NDM and PBP3 inserts impacts aztreonam/avibactam activity and reduces the susceptibility to 40 % in E. coli isolates. While, aztreonam/avibactam showed potent activity against NDM-expressing K. pneumoniae isolates. Importantly, cefepime/taniborbactam and cefiderocol showed limited activity against NDM-expressing E. coli and K. pneumoniae isolates. The pentaplex PCR was effective in detecting four beta-lactamases (bla CTX-M, bla OXA-1, bla CMY, bla NDM ) as well as PBP3 inserts. It is expected that using pentaplex PCR as a diagnostic test for resistance detection in clinical practice will improve patient outcomes by providing prompt and targeted treatment.

Bibliographic Details

Bakthavatchalam, Yamuna Devi; Abdullah, Fizaa; Srinivasan, Devishree; Nithiyanandam, Sangeetha; Neeravi, Ayyanraj; Shah, Poojah; Subburaju, Nivedhana; Jaganathan, Subha Vajjiravelu; Devi, Rema; Nataraj, Gita; Yesudason, Binesh Lal; Walia, Kamini; Veeraraghavan, Balaji

Elsevier BV

Medicine; Immunology and Microbiology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know